Publications by authors named "Robert H Shoemaker"

83Publications

Cancer Immunoprevention: Challenges and Potential Opportunities for Use of Immune Checkpoint Inhibitors.

Cancer Prev Res (Phila) 2020 Sep 18. Epub 2020 Sep 18.

Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-20-0432DOI Listing
September 2020

Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator.

EBioMedicine 2019 Nov 31;49:72-81. Epub 2019 Oct 31.

Center for Disease Prevention Research and Department of Pharmacology & Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.10.044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945201PMC
November 2019

Evaluation of the STAT3 inhibitor GLG‑302 for the prevention of estrogen receptor‑positive and ‑negative mammary cancers.

Oncol Rep 2019 Sep 4;42(3):1205-1213. Epub 2019 Jul 4.

Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2019.7219DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918811PMC
September 2019

Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression.

Cancer Prev Res (Phila) 2018 10 25;11(10):595-606. Epub 2018 Jul 25.

Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-18-0084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186395PMC
October 2018

Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide.

Invest New Drugs 2018 10 14;36(5):797-809. Epub 2018 Feb 14.

Departments of Rheumatology, Amsterdam Rheumatology and Immunology Center, Cancer Center Amsterdam, Rm 2.46, VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0569-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153520PMC
October 2018

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine.

Oncotarget 2017 Oct 1;8(47):82689-82699. Epub 2017 Aug 1.

Cancer Center and Department of Pharmacology & Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19831DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669920PMC
October 2017

Targeting "Retired Antigens" for Cancer Immunoprevention.

Cancer Prev Res (Phila) 2017 11;10(11):607-608

Department of Biology, University of Texas at San Antonio, San Antonio, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-17-0188DOI Listing
November 2017

The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets.

Semin Oncol 2016 Feb 8;43(1):189-197. Epub 2015 Sep 8.

Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.09.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789768PMC
February 2016

Werner syndrome helicase has a critical role in DNA damage responses in the absence of a functional fanconi anemia pathway.

Cancer Res 2013 Sep 18;73(17):5497-507. Epub 2013 Jul 18.

Laboratory of Molecular Gerontology, National Institute on Aging, NIH Biomedical Research Center, NIH, Baltimore, MD 21224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-2975DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766423PMC
September 2013

Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma.

PLoS One 2012 3;7(8):e41401. Epub 2012 Aug 3.

Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041401PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411700PMC
February 2013

Discovery and preliminary SAR of bisbenzylisoquinoline alkaloids as inducers of C/EBPα.

Bioorg Med Chem 2012 Aug 16;20(15):4646-52. Epub 2012 Jun 16.

Natural Products Support Group, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702-1201, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S096808961200495
Publisher Site
http://dx.doi.org/10.1016/j.bmc.2012.06.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430122PMC
August 2012

Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy.

J Struct Biol 2011 Dec 22;176(3):292-301. Epub 2011 Sep 22.

Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsb.2011.09.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210331PMC
December 2011

Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors.

Eur J Med Chem 2011 Sep 8;46(9):4311-23. Epub 2011 Jul 8.

Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2011.07.001DOI Listing
September 2011

Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA.

Biochemistry 2011 Aug 21;50(33):7218-27. Epub 2011 Jul 21.

Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi200853yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220277PMC
August 2011

Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.

J Natl Cancer Inst 2011 Jul 17;103(13):1018-36. Epub 2011 Jun 17.

Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr190DOI Listing
July 2011

ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma.

J Pediatr Hematol Oncol 2011 Jul;33(5):360-8

Screening Technologies Branch, Developmental Therapeutics Program, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e3182002f9fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518051PMC
July 2011

Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.

Neoplasia 2011 Feb;13(2):131-44

Experimental and Clinical Research Center, Charité University Medicine, at the Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033592PMC
http://dx.doi.org/10.1593/neo.101172DOI Listing
February 2011

Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress.

Proc Natl Acad Sci U S A 2011 Jan 10;108(4):1525-30. Epub 2011 Jan 10.

Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health Biomedical Research Center, Baltimore, MD 21224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1006423108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029756PMC
January 2011

Adaphostin toxicity in a sensitive non-small cell lung cancer model is mediated through Nrf2 signaling and heme oxygenase 1.

J Exp Clin Cancer Res 2010 Jul 9;29:91. Epub 2010 Jul 9.

Laboratory of Functional Genomics, SAIC-Frederick Inc., NCI-Frederick, 1050 Boyles Street, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://jeccr.biomedcentral.com/articles/10.1186/1756-9966-29
Publisher Site
http://dx.doi.org/10.1186/1756-9966-29-91DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909968PMC
July 2010

Antitumor activity and COMPARE analysis of bis-indole derivatives.

Bioorg Med Chem 2010 May 28;18(9):3004-11. Epub 2010 Mar 28.

Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2010.03.063DOI Listing
May 2010

12 Arylstibonic acids that inhibit the DNA binding of five B-ZIP dimers.

J Struct Biol 2010 May 20;170(2):216-25. Epub 2010 Feb 20.

Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Building 37, Room 3128, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsb.2010.02.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377350PMC
May 2010

Identification of bona fide esophageal adenocarcinoma cell lines.

J Natl Cancer Inst 2010 Feb 14;102(4):212-3. Epub 2010 Jan 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djp526DOI Listing
February 2010

RSK2 Binding Models Delineate Key Features for Activity.

J Chem Pharm Res 2010 ;2(5):587-598

Information Technology Branch, Developmental Therapeutics Program, National Cancer Institute, Frederick, Maryland 21702 (USA).

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094916PMC
January 2010

Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads.

Cell Cycle 2009 Dec 21;8(24):4040-3. Epub 2009 Dec 21.

SAIC Frederick, Inc., Frederick, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.8.24.10145DOI Listing
December 2009

Potential for therapeutic targeting of tumor stem cells.

Cancer Sci 2010 Jan 22;101(1):16-21. Epub 2009 Sep 22.

Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2009.01371.xDOI Listing
January 2010

Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts.

Anticancer Drugs 2009 Sep;20(8):682-92

aSTB Laboratory of Functional Genomics, SAIC-Frederick Inc., PO Box B, NCI-Frederick, 1032 Boyles Street, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e32832e14e1DOI Listing
September 2009

Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells.

Mol Cancer 2009 Jul 14;8:47. Epub 2009 Jul 14.

Laboratory of Human Toxicology and Pharmacology, SAIC-Frederick, Inc, NCI-Frederick, Frederick, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-8-47DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723073PMC
July 2009

Cytotoxic and HIF-1alpha inhibitory compounds from Crossosoma bigelovii.

J Nat Prod 2009 May;72(5):805-12

Natural Products Support Group, SAIC-Frederick, Inc, NCI-Frederick, Frederick, Maryland 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/np8006342DOI Listing
May 2009

Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor.

Protein Sci 2009 Jan;18(1):92-100

Macromolecular Crystallography Laboratory, National Cancer Institute at Frederick, P. O. Box B, Frederick, Maryland 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pro.16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708046PMC
January 2009

Gene expression profiling of alveolar soft-part sarcoma (ASPS).

BMC Cancer 2009 Jan 15;9:22. Epub 2009 Jan 15.

Screening Technologies Branch, Developmental Therapeutics Program, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-9-22DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635365PMC
January 2009

Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa.

J Nat Prod 2009 Mar;72(3):336-9

Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/np800350xDOI Listing
March 2009

Induction of apoptosis in human cancer cells by candidaspongiolide, a novel sponge polyketide.

J Natl Cancer Inst 2008 Sep 26;100(17):1233-46. Epub 2008 Aug 26.

Tumor Hypoxia Laboratory, SAIC-Frederick, Inc., National Cancer Institute, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djn239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720712PMC
September 2008

Separation and SAR study of HIF-1alpha inhibitory tubulosines from Alangium cf. longiflorum.

Planta Med 2008 Feb 26;74(3):258-63. Epub 2008 Feb 26.

Natural Products Support Group, SAIC-Frederick Inc., NCI Frederick, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2008-1034315DOI Listing
February 2008

Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma.

J Pediatr Hematol Oncol 2008 Jan;30(1):46-52

Screening Technologies Branch, Developmental Therapeutics, National Cancer Institute, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/jpho-online/2008/01000/11.pdf
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MPH.0b013e31815d1d6fDOI Listing
January 2008

Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells.

Cancer Res 2008 Jan;68(1):285-91

Developmental Therapeutics Program, National Cancer Institute-Frederick, Frederick, Maryland 21702, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-07-5564DOI Listing
January 2008

Identification of a new natural camptothecin analogue in targeted screening for HIF-1alpha inhibitors.

Planta Med 2007 Jan;73(1):49-52

Natural Products Support Group, SAIC-Frederick, Inc, NCI Frederick, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2006-951767DOI Listing
January 2007

Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.

Clin Cancer Res 2007 Feb;13(3):1010-8

Screening Technologies Branch, Developmental Therapeutics Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2301DOI Listing
February 2007

Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines.

Biochem Pharmacol 2007 Feb 13;73(3):331-40. Epub 2006 Oct 13.

Developmental Therapeutics Program, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2006.10.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808352PMC
February 2007

The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.

Gastroenterology 2006 Nov 22;131(5):1486-500. Epub 2006 Aug 22.

Department of Surgery and Surgical Oncology, Robert-Rössle Cancer Hospital, Charité Campus Buch, Berlin, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S001650850601801
Publisher Site
http://dx.doi.org/10.1053/j.gastro.2006.08.041DOI Listing
November 2006

The NCI60 human tumour cell line anticancer drug screen.

Nat Rev Cancer 2006 10;6(10):813-23

Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc1951DOI Listing
October 2006

Targeting the PAS-A domain of HIF-1alpha for development of small molecule inhibitors of HIF-1.

Cell Cycle 2006 Aug 15;5(16):1847-53. Epub 2006 Aug 15.

Science Applications International Corporation, Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.5.16.3019DOI Listing
August 2006

Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore.

Bioorg Med Chem 2006 Sep 24;14(17):6097-105. Epub 2006 May 24.

Target Structure-based Drug Discovery Group, SAIC-Frederick, Inc., NCI Frederick, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2006.05.001DOI Listing
September 2006

Antifungal flavonoids from Hildegardia barteri.

J Nat Prod 2005 Dec;68(12):1790-2

Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute-Frederick, Frederick, Maryland 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/np0503000DOI Listing
December 2005

Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells.

Blood 2006 Apr 22;107(7):2705-12. Epub 2005 Nov 22.

DTP-Tumor Hypoxia Laboratory, Bldg 432, Rm 218, National Cancer Institute at Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-09-3541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895390PMC
April 2006

Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.

Cancer Res 2005 Oct;65(19):9047-55

Science Applications International Corporation-Frederick, Inc., Frederick, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1235DOI Listing
October 2005

Aspirochlorine class compounds from Aspergillus flavus inhibit azole-resistant Candida albicans.

J Nat Prod 2005 Aug;68(8):1300-2

Natural Products Support Group, SAIC-Frederick, Inc., Bldg 431, FCRDC, Frederick, Maryland 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/np050141kDOI Listing
August 2005

Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.

J Virol 2005 May;79(10):6122-33

Laboratory of Antiviral Drug Mechanisms, Screening Technologies Branch, Developmental Therapeutics Program, SAIC-Frederick, NCI-Frederick, Bldg. 439, P.O. Box B, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.79.10.6122-6133.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1091715PMC
May 2005

A novel antimicrobial indolizinium alkaloid from Aniba panurensis.

J Nat Prod 2004 Oct;67(10):1732-5

Natural Products Support Group, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc, National Cancer Institute-Frederick, Maryland 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/np040114eDOI Listing
October 2004

Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications.

Cancer Res 2004 Feb;64(4):1475-82

Developmental Therapeutics Program, Tumor Hypoxia Laboratory, Science Applications Corporation-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.can-03-3139DOI Listing
February 2004

Targeting topoisomerase I to inhibit hypoxia inducible factor 1.

Cell Cycle 2004 Feb;3(2):172-5

Developmental Therapeutics Program, Science Applications International Corporation, Frederick, Inc; National Cancer Institute at Frederick, Frederick, Maryland 21702, USA.

View Article

Download full-text PDF

Source
February 2004

Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data.

Bioinformatics 2003 Nov;19(17):2212-24

Science Applications International Corporation, National Cancer Institute at Frederick, National Institutes of Health Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btg302DOI Listing
November 2003

Mining the NCI screening database: explorations of agents involved in cell cycle regulation.

Prog Cell Cycle Res 2003 ;5:173-9

NCI-Frederick, SAIC-Frederick, Developmental Therapeutics Program, Screening Technologies Branch, Laboratory of Computational Technologies, Bldg 1052, Room 238, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
December 2003

Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology.

Mol Cancer Ther 2002 Mar;1(5):311-20

Science Applications International Corporation, Frederick, Maryland 21702, USA.

View Article

Download full-text PDF

Source
March 2002

Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

Cancer Res 2002 Aug;62(15):4316-24

Developmental Therapeutics Program-Tumor Hypoxia Laboratory, Science Applications International Corporation-Frederick, Inc. and National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702-1201, USA.

View Article

Download full-text PDF

Source
August 2002

Expression of the vascular endothelial cell protein C receptor in epithelial tumour cells.

Eur J Cancer 2002 Jul;38(11):1535-42

Department of Pathology, Free University Medical Center, De Boelelaan 1117 1081 HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0959-8049(02)00108-9DOI Listing
July 2002

Application of high-throughput, molecular-targeted screening to anticancer drug discovery.

Curr Top Med Chem 2002 Mar;2(3):229-46

Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute-Frederick, Maryland 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568026023394317DOI Listing
March 2002

Mining the National Cancer Institute's tumor-screening database: identification of compounds with similar cellular activities.

J Med Chem 2002 Feb;45(4):818-40

Science Applications International Corporation and Developmental Therapeutics Program, DCTD, National Cancer Institute/NIH, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm010385bDOI Listing
February 2002